Risks of Tramadol Likely Outweigh Benefit for Chronic Pain

(MedPage Today) — The opioid analgesic tramadol reduced chronic pain levels compared with placebo, but appeared to double the risk of harm, a review of 19 clinical trials suggested.
In a meta-analysis and trial sequential analysis, tramadol improved…

Related posts

RFK Jr. ‘Endangering the Health of the Nation,’ Former Surgeons General Say

New Drug Approved for Deadly Lung Condition, First in Over a Decade

Amid Shutdown Fight, Healthcare Is One of the Most Intractable Issues in Congress